Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541293 · ClinicalTrials.gov registry record · Phase 1
Intrauterine Lidocaine for Laminaria
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT01541293 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 72 participants.
The verdict
NCT01541293, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocaine in addition to a paracervical block will experience less pain than women who receive only a paracervical block.
Interventions
- DRUG Lidocaine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01541293
The ClinicalTrials.gov registry entry for NCT01541293 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT01541293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01541293 about?
NCT01541293 is a clinical study titled "Intrauterine Lidocaine for Laminaria". This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocain...
What is the current status of trial NCT01541293?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2012-09. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01541293?
The interventions under investigation include: Lidocaine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01541293?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.